Melanoma Clinical Trials in Houston

Showing 201-220 of 268 trials

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

NCT01010984

The purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.

Stage IV Melanoma

Robert C. Martin20 participantsStarted Sep 2009

Louisville, Kentucky, United States • Philadelphia, Pennsylvania, United States • Houston, Texas, United States

UNKNOWNPhase 1< 1 mile

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

NCT03098160

An immunotherapy study combining ipilimumab and evofosfamide for the treatment of patients with confirmed metastatic or locally advanced prostate cancer, metastatic pancreatic cancer, melanoma or human papillomavirus (HPV) negative squamous cell carcinoma of head and neck that have failed to respond to standard therapy, progressed despite standard therapy, for which standard therapy does not offer the potential for increased survival.

Pancreatic CancerMelanomaSquamous Cell Carcinoma of the Head and Neck+1 more

Threshold Pharmaceuticals69 participantsStarted May 2017

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

Safety Study of PLX4032 in Patients With Solid Tumors

NCT00405587

The primary objective of this FIH study is to assess the safety and pharmacokinetics of PLX4032 in patients with solid tumors. The secondary objective is to assess the pharmacodynamic activity in paired biopsy specimens obtained from patients with malignant melanoma who have the V600E BRAF oncogenic mutation.

Malignant MelanomaColorectal Carcinoma

Plexxikon109 participantsStarted Nov 2006

Los Angeles, California, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +4 more locations

LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Safety Study of PLX4032 in Patients With Solid Tumors

Melanoma Trials in Other Cities

Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Prospective Measurement of Post-Treatment Lymphedema

Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma

In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

A Study of Vemurafenib in Participants With Metastatic Melanoma

A Study of Tasisulam in Treating Participants With Malignant Melanoma

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System

Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)

Other Conditions in Houston